Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Handen

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
The striatum is an early, accurate indicator of amyloid burden using [<sup>11</sup>C]PiB in Down syndrome: comparison of two radiotracersMax McLachlan, Brecca Bettcher, Andrew McVea, et al.
Ebiomedicine|November 5, 2024
The effects of mosaicism on biological and clinical markers of Alzheimer's disease in adults with Down syndromeLaura Xicota, Lam-Ha T Dang, Alice Lee, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 21, 2026
The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndromeJulianne G Clina, Brian C Helsel, Sigan L Hartley, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 7, 2020
Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) studyMelissa E Petersen, Fan Zhang, Nicole Schupf, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 24, 2012
Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problemsLawrence Scahill, Christopher J McDougle, Michael G Aman, et al.
Journal of Alzheimer'S Disease : JAD|December 18, 2020
Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down SyndromeMelissa E Petersen, Michael S Rafii, Fan Zhang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 7, 2025
The striatum is an early, accurate indicator of amyloid burden using [<sup>11</sup>C]PiB in Down syndrome: Comparison of two radiotracersMax McLachlan, Brecca Bettcher, Andrew McVea, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 28, 2009
Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trialMichael G Aman, Christopher J McDougle, Lawrence Scahill, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2025
Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 ConferenceNeus Falgàs, Lucia Maure-Blesa, Beau Ances, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Medrxiv : the Preprint Server for Health Sciences|December 16, 2024
The striatum is an early, accurate indicator of amyloid burden using [<sup>11</sup>C]PiB in Down syndrome: comparison of two radiotracersMax McLachlan, Brecca Bettcher, Andrew McVea, et al.
Ebiomedicine|November 5, 2024
The effects of mosaicism on biological and clinical markers of Alzheimer's disease in adults with Down syndromeLaura Xicota, Lam-Ha T Dang, Alice Lee, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|January 21, 2026
The impact of congenital heart disease on the timing of Alzheimer's disease in Down syndromeJulianne G Clina, Brian C Helsel, Sigan L Hartley, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 7, 2020
Proteomic profiles for Alzheimer's disease and mild cognitive impairment among adults with Down syndrome spanning serum and plasma: An Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS) studyMelissa E Petersen, Fan Zhang, Nicole Schupf, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 24, 2012
Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problemsLawrence Scahill, Christopher J McDougle, Michael G Aman, et al.
Journal of Alzheimer'S Disease : JAD|December 18, 2020
Plasma Total-Tau and Neurofilament Light Chain as Diagnostic Biomarkers of Alzheimer's Disease Dementia and Mild Cognitive Impairment in Adults with Down SyndromeMelissa E Petersen, Michael S Rafii, Fan Zhang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 7, 2025
The striatum is an early, accurate indicator of amyloid burden using [<sup>11</sup>C]PiB in Down syndrome: Comparison of two radiotracersMax McLachlan, Brecca Bettcher, Andrew McVea, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|October 28, 2009
Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trialMichael G Aman, Christopher J McDougle, Lawrence Scahill, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 3, 2025
Genetically determined Alzheimer's disease research advances: The Down Syndrome & Autosomal Dominant Alzheimer's Disease 2024 ConferenceNeus Falgàs, Lucia Maure-Blesa, Beau Ances, et al.
Pageof 5